General Information of the Compound
Compound ID
CP0013833
Compound Name
MLN-4924
    Show/Hide
Synonyms
((1S,2S,4R)-4-(4-(((S)-2,3-dihydro-1H-inden-1-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulfamate
3gzn
905579-51-3
C21H25N5O4S
MLN 4924
MLN-4924
MLN4924
Pevonedistat
Pevonedistat [USAN:INN]
S3AZD8D215
Sulfamic acid [(1S,2S,4R)-4-[4-[[(1S)-2,3-dihydro-1H-inden-1-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-7-yl]-2-hydroxycyclopentyl]methyl ester
UNII-S3AZD8D215
[(1s,2s,4r)-4-{4-[(1s)-2,3-Dihydro-1h-Inden-1-Ylamino]-7h-Pyrrolo[2,3-D]pyrimidin-7-Yl}-2-Hydroxycyclopentyl]methyl Sulfamate
    Show/Hide
Structure
Formula
C21H25N5O4S
Molecular Weight
443.529
Canonical SMILES
NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n1ccc2c(N[C@H]3CCc4ccccc34)ncnc12
    Show/Hide
InChI
InChI=1S/C21H25N5O4S/c22-31(28,29)30-11-14-9-15(10-19(14)27)26-8-7-17-20(23-12-24-21(17)26)25-18-6-5-13-3-1-2-4-16(13)18/h1-4,7-8,12,14-15,18-19,27H,5-6,9-11H2,(H2,22,28,29)(H,23,24,25)/t14-,15+,18-,19-/m0/s1
    Show/Hide
InChIKey
MPUQHZXIXSTTDU-QXGSTGNESA-N
CAS
905579-51-3
Physicochemical Property
logP
2.0628
Rotatable Bonds
6
Heavy Atom Count
31
Polar Areas
132.36
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
8
Complexity
31

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 16720766
SID: 26674965
ChEMBL ID
CHEMBL1231160
DrugBank ID
DB11759
Clinical Information about the Compound
Drug 1 ( MLN4924 )
Drug Name MLN4924
Company Takeda
Indication
Myelodysplastic syndrome
Phase 3
Acute myelogenous leukaemia
Phase 2
Advanced malignancy
Phase 1
Nasopharyngeal carcinoma
Investigative
Target(s)
Ubiquitin-like protein Nedd8 (NEDD8)
Inhibitor